Omega Healthcare - OHI STOCK NEWS

Omega Healthcare Investors (NYSE: OHI) reported strong Q4 2024 results with net income of $116 million ($0.41 per share), up from $57 million in Q4 2023. The company completed $340 million in new investments during Q4, including $179 million in real estate acquisitions and $162 million in real estate loans.

Full-year 2024 highlights include net income of $418 million ($1.55 per share), completion of $1.1 billion in new investments, and issuance of 34 million common shares raising $1.2 billion. The company successfully reduced leverage from 5x to below 4x and improved operational metrics with modest improvements in occupancy and coverage.

For 2025, Omega provided Adjusted FFO guidance of $2.90-$2.98 per diluted share. The company maintains a strong balance sheet with $518.3 million in cash and $1.45 billion in undrawn credit facility capacity as of December 31, 2024.

Omega Healthcare Investors (NYSE:OHI) has announced its quarterly cash dividend of $0.67 per share on common stock. The dividend will be paid on February 18, 2025, to stockholders of record as of February 10, 2025.

OHI operates as a real estate investment trust focused on long-term healthcare industry investments, primarily in skilled nursing and assisted living facilities. The company's portfolio consists of properties operated by various healthcare companies under triple-net lease structures, with assets located throughout the United States and the United Kingdom.

Omega Healthcare Investors (NYSE:OHI) has scheduled its fourth quarter 2024 earnings release for Wednesday, February 5, 2025, after market close. The company will host a conference call on Thursday, February 6, 2025, at 10 a.m. Eastern Time to discuss the results and current developments.

Investors can access the conference call via webcast through Omega's website, with replays available for approximately two weeks following the call. U.S. participants can dial (800) 715-9871, while international callers should use +1 (646) 307-1963, with conference ID 1388157.

Omega is a real estate investment trust specializing in long-term healthcare facilities, primarily skilled nursing and assisted living facilities, with properties across the US and UK operated under triple-net lease structures.

Omega Healthcare Investors (NYSE:OHI) announced significant leadership changes as part of its long-term succession planning. Matthew Gourmand, formerly Senior VP of Corporate Strategy & Investor Relations, has been appointed as President, while Vikas Gupta, previously Senior VP of Acquisitions & Development, has been named Chief Investment Officer.

After 23 years of service, Dan Booth has stepped down from his position as Chief Operating Officer but will continue in a consulting role for 12 months. CEO Taylor Pickett expressed confidence in the new appointments, citing their industry experience, business acumen, and work ethic as key factors for driving the company's next growth phase.

Omega is a REIT specializing in long-term healthcare facilities, primarily skilled nursing and assisted living facilities, with assets across the US and UK operated under triple-net lease structures.

Omega Healthcare Investors (NYSE: OHI) reported strong Q3 2024 results with net income of $115 million ($0.42 per share), up from $94 million in Q3 2023. The company completed $834 million in new investments year-to-date, including $440 million in Q3. Revenue increased by $34 million to $276 million compared to Q3 2023. The company raised its 2024 AFFO guidance to $2.84-$2.86 per share from previous $2.78-$2.84. Notable Q3 activities include issuing 14 million common shares for $530 million and acquiring the remaining 51% stake in Cindat JV for $100.9 million plus assumed mortgage.

Omega Healthcare Investors (NYSE:OHI) has declared a quarterly cash dividend of $0.67 per share on its common stock. The dividend will be paid on November 15, 2024, to stockholders of record as of November 4, 2024. Omega is a real estate investment trust specializing in healthcare facilities, primarily skilled nursing and assisted living facilities, with properties across the US and UK operated under triple-net lease structures.

Inspīr Carnegie Hill, Maplewood Senior Living's luxury senior living property in New York City, has won the 2024 Senior Living Development Award from The Americas Property Awards. This prestigious accolade recognizes Inspīr's innovation in senior living design, wellness offerings, and personalized care.

The property distinguishes itself through exquisite design fostering a connection to nature, state-of-the-art technology enhancing resident care, and access to Manhattan's world-class amenities. Inspīr is expanding with a second location in Washington D.C., set to open in January 2025.

Inspīr offers assisted living, memory care, and enhanced care options in customized private apartments. The brand is developed by Maplewood Senior Living in partnership with Omega Healthcare Investors, Inc. (NYSE: OHI).

Omega Healthcare Investors (NYSE:OHI) has announced its schedule for releasing third quarter 2024 earnings results. The company will release its earnings for the quarter ended September 30, 2024, on Wednesday, October 30, 2024, after market close. Following this, Omega will conduct a conference call on Thursday, October 31, 2024, at 10 a.m. Eastern Time to review the Q3 2024 results and current developments.

Investors can access the conference call via webcast on Omega's website or by phone. The US dial-in number is (800) 715-9871, while the international toll-free number is +1 (646) 307-1963. The conference ID is 1388157. Participants are advised to dial in 15 minutes before the call starts. Webcast replays will be available on the website for about two weeks after the call.

Omega Healthcare Investors (NYSE: OHI) reported Q2 2024 results with net income of $117 million ($0.45 per share), up from $62 million in Q2 2023. Nareit FFO increased to $189 million ($0.72 per share) from $155 million. The company completed $221 million in new investments during Q2, including $115 million in real estate acquisitions and $106 million in real estate loans. Year-to-date, Omega has invested $648 million in new investments. Due to strong performance, Omega increased its 2024 AFFO guidance to $2.78-$2.84 per share from the previous $2.70-$2.80. The company also reported improvements in tenant operating metrics and portfolio coverage.